EyePoint Pharmaceuticals
EYPT
#5849
Rank
ยฃ0.78 B
Marketcap
ยฃ9.43
Share price
-4.29%
Change (1 day)
109.19%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -ยฃ0.17 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ42.34 Million. In 2024 the company made an earning of -ยฃ0.11 Billion a decrease over its 2023 earnings that were of -ยฃ52.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.17 Billion51.54%
2024 -ยฃ0.11 Billion104.29%
2023 -ยฃ52.39 Million-29.88%
2022 -ยฃ74.71 Million87.2%
2021 -ยฃ39.91 Million38.58%
2020 -ยฃ28.8 Million-24.56%
2019 -ยฃ38.17 Million
2017 -ยฃ17.41 Million22.59%
2016 -ยฃ14.21 Million-8.02%
2015 -ยฃ15.44 Million-296.09%
2014 ยฃ7.87 M-174.02%
2013 -ยฃ10.64 Million37.42%
2012 -ยฃ7.74 Million-56.29%
2011 -ยฃ17.71 Million-1062.38%
2010 ยฃ1.83 M-250.43%
2009 -ยฃ1.23 Million-89.5%
2008 -ยฃ11.66 Million
2005 -ยฃ7.19 Million56.99%
2004 -ยฃ4.58 Million73.7%
2003 -ยฃ2.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-ยฃ1.63 Million-98.99% Bahamas
NRC Health
NRC
ยฃ20.79 M-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA